BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37577984)

  • 1. ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma.
    Costentin C; Audureau E; Park YN; Langella S; Vibert E; Laurent A; Cauchy F; Scatton O; Chirica M; Rhaiem R; Boleslawski E; di Tommaso L; Ferrero A; Yano H; Akiba J; Donadon M; Nebbia M; Detry O; Honoré P; Di Martino M; Schwarz L; Barbier L; Nault JC; Rhee H; Lim C; Brustia R; Paradis V; Guettier C; Le Bail B; Okumura S; Blanc JF; Calderaro J
    Liver Int; 2023 Nov; 43(11):2538-2547. PubMed ID: 37577984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: An implication for adjuvant therapy and postoperative surveillance.
    Ng KK; Cheung TT; Pang HH; Wong TC; Dai JW; Ma KW; She WH; Kotewall CN; Lo CM
    Surg Oncol; 2019 Sep; 30():6-12. PubMed ID: 31500787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation.
    Costentin C; Piñero F; Degroote H; Notarpaolo A; Boin IF; Boudjema K; Baccaro C; Podestá LG; Bachellier P; Ettorre GM; Poniachik J; Muscari F; Dibenedetto F; Duque SH; Salame E; Cillo U; Marciano S; Vanlemmens C; Fagiuoli S; Burra P; Van Vlierberghe H; Cherqui D; Lai Q; Silva M; Rubinstein F; Duvoux C;
    JHEP Rep; 2022 May; 4(5):100445. PubMed ID: 35360522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid-enhanced MRI: risk scoring system development and validation.
    Park SH; Kim B; Kim S; Park S; Park YH; Shin SK; Sung PS; Choi JI
    Eur Radiol; 2023 May; 33(5):3566-3579. PubMed ID: 36933020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion.
    Mai RY; Zeng J; Meng WD; Lu HZ; Liang R; Lin Y; Wu GB; Li LQ; Ma L; Ye JZ; Bai T
    BMC Cancer; 2021 Mar; 21(1):283. PubMed ID: 33726693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
    Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
    Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.
    Chan AWH; Zhong J; Berhane S; Toyoda H; Cucchetti A; Shi K; Tada T; Chong CCN; Xiang BD; Li LQ; Lai PBS; Mazzaferro V; García-Fiñana M; Kudo M; Kumada T; Roayaie S; Johnson PJ
    J Hepatol; 2018 Dec; 69(6):1284-1293. PubMed ID: 30236834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study.
    Yoon JH; Choi SK; Cho SB; Kim HJ; Ko YS; Jun CH
    World J Gastroenterol; 2022 Sep; 28(36):5351-5363. PubMed ID: 36185633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
    Wang XH; Liu QB; Xiang CL; Mao XH; Yang B; Li Q; Zhou QF; Li SQ; Zhou ZG; Chen MS
    Int J Cancer; 2021 Jul; 149(1):127-138. PubMed ID: 33586134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.
    Shim JH; Jun MJ; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
    Ann Surg; 2015 May; 261(5):939-46. PubMed ID: 24950276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
    Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
    Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
    Mehta N; Heimbach J; Harnois DM; Sapisochin G; Dodge JL; Lee D; Burns JM; Sanchez W; Greig PD; Grant DR; Roberts JP; Yao FY
    JAMA Oncol; 2017 Apr; 3(4):493-500. PubMed ID: 27838698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.
    Hsu HY; Yu MC; Lee CW; Tsai HI; Sung CM; Chen CW; Huang SW; Lin CY; Jeng WJ; Lee WC; Chen MF
    BMC Cancer; 2017 Nov; 17(1):742. PubMed ID: 29121890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of adjuvant transarterial chemoembolization for hepatocellular carcinoma after liver resection based on risk stratification.
    Zeng JS; Zeng JX; Huang Y; Liu JF; Zeng JH
    Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):482-489. PubMed ID: 35934610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma.
    el-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Yu L; Nagasue N
    Surgery; 1997 Sep; 122(3):571-7. PubMed ID: 9308615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-factor preoperative scoring model predicts risk of recurrence after liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function.
    Li Y; Ruan DY; Yi HM; Wang GY; Yang Y; Jiang N
    Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):477-84. PubMed ID: 26459723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.